Finance, Money & Credit
Finance & Money – Discussions & Reviews
Skip to content
Menu
News
Blogs
AstraZeneca lifts revenue guidance on COVID treatment
by
admin
Posted on
July 29, 2022
Published by
admin
View all posts by admin
Post navigation
Prev
AstraZeneca Non-GAAP EPS of $1.72 beats by $0.14, revenue of $10.77B beats by $250M
Next
Taxpayers left with £421m bill after one in 12 firms default on Covid loans
